EpiBiome, a past winner of Johnson & Johnson's JLabs QuickFire Challenge, has raised $6m in an Alexandria Real Estate Equities-backed round
US-based biotechnology developer EpiBiome recently completed a $6m series A round with participation from Alexandria Venture Investments, the strategic investment arm of property firm Alexandria Real Estate Equities.
The round also included investment firm Viking Global Investors, which took part through the Illumina Accelerator Boost Capital fund, hedge fund manager Matrix Capital Management and venture capital firms SV Tech Ventures and China Rock Capital Management.
EpiBiome develops therapies to combat infectious diseases in humans and agriculture without the use of…
